These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37965055)

  • 1. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Lung Adenocarcinoma.
    Sun L; Li W; Zhao Z; Zuo Y; Han Z
    Int J Genomics; 2023; 2023():8766311. PubMed ID: 37965055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
    He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
    Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma.
    Wang N; Liu D
    Onco Targets Ther; 2021; 14():5373-5383. PubMed ID: 34880629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma.
    Song Y; Zhang J; Fang L; Liu W
    Front Genet; 2022; 13():1027741. PubMed ID: 36506314
    [No Abstract]   [Full Text] [Related]  

  • 5. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients.
    Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B
    Front Genet; 2022; 13():966896. PubMed ID: 36186456
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of molecular subtypes, risk signature, and immune landscape mediated by necroptosis-related genes in non-small cell lung cancer.
    Zhu J; Wang J; Wang T; Zhou H; Xu M; Zha J; Feng C; Shen Z; Jiang Y; Chen J
    Front Oncol; 2022; 12():955186. PubMed ID: 35965497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 9. Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma.
    Qian C; Jiang Z; Zhou T; Wu T; Zhang Y; Huang J; Ouyang J; Dong Z; Wu G; Cao J
    Front Immunol; 2022; 13():1034992. PubMed ID: 36524130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a necroptosis-related gene prognostic signature for colon adenocarcinoma.
    Zhang J; Liu Z; Chen W; Liu H
    Transl Cancer Res; 2023 Sep; 12(9):2239-2255. PubMed ID: 37859737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
    Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
    Front Immunol; 2022; 13():783495. PubMed ID: 35222371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma.
    Zeng C; Yu H; Liu X; Liu Q; Jin J
    Biomed Res Int; 2022; 2022():9710540. PubMed ID: 36330457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma.
    Chen JH; Wu X; Wang ZM; Liu ZY; He BX; Song WP; Zhang WZ
    J Thorac Dis; 2023 Mar; 15(3):1373-1386. PubMed ID: 37065578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
    Lei K; Tan B; Liang R; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
    Am J Cancer Res; 2022; 12(11):5160-5182. PubMed ID: 36504901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer.
    Zhan J; Yang F; Ge C; Yu X
    Int J Gen Med; 2022; 15():4937-4948. PubMed ID: 35592536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs.
    Diao X; Guo C; Li S
    Front Genet; 2022; 13():833362. PubMed ID: 35938013
    [No Abstract]   [Full Text] [Related]  

  • 19. Analysis of the Prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation.
    Guan R; Mei J; Guo R
    Technol Cancer Res Treat; 2023; 22():15330338231182208. PubMed ID: 37335078
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of necroptosis-related gene signature and characterization of tumour microenvironment infiltration in non-small-cell lung cancer.
    Dai J; Fu Y
    J Cell Mol Med; 2022 Sep; 26(17):4698-4709. PubMed ID: 35871768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.